Xikang Cloud Hospital Holdings (9686) H1 2023 earnings summary

Executive summary

• H1 2023 revenue fell 9.3% YoY to RMB218.9m, while gross profit rose 46.6% to RMB67.3m and gross margin expanded to 30.7%.

• Net loss narrowed 39.6% YoY to RMB95.0m; adjusted net loss, excluding share-based compensation and redeemable-right interest, narrowed to RMB80.3m from RMB104.3m.

Financial highlights

• Revenue declined from RMB241.5m, mainly due to lower smart healthcare product sales; cost of sales and services fell 22.5% to RMB151.6m.

• Operating loss narrowed to RMB77.2m from RMB136.0m; loss before tax was RMB96.3m versus RMB156.5m, and loss attributable to owners was RMB94.5m versus RMB154.9m.

• Other income fell to RMB0.7m from RMB14.4m, primarily on lower government grants; net other losses were RMB6.4m versus net other gains of RMB1.2m.

• Selling and marketing, R&D and administrative expenses declined 20.6%, 33.3% and 22.9% YoY, respectively, largely reflecting lower share-based compensation and staffing costs.

Outlook and guidance

• H2 priorities: extend the cloud hospital network, deepen existing platform capabilities, strengthen specialist collaborations and broaden specialty-based services.

• Planned technology investment will improve platform infrastructure, data processing and security, with greater integration of big data analytics, AI and blockchain.